Literature DB >> 21213101

Mdm2 links genotoxic stress and metabolism to p53.

Zhongfeng Wang1, Baojie Li.   

Abstract

Mouse double minute 2 (Mdm2) gene was isolated from a cDNA library derived from transformed mouse 3T3 cells, and was classified as an oncogene as it confers 3T3 and Rat2 cells tumorigenicity when overexpressed. It encodes a nucleocytoplasmic shuttling ubiquitin E3 ligase, with its main target being tumor suppressor p53, which is mutated in more than 50% of human primary tumors. Mdm2's oncogenic activity is mainly mediated by p53, which is activated by various stresses, especially genotoxic stress, via Atm (ataxia telangiectasia mutated) and Atr (Atm and Rad3-related). Activated p53 inhibits cell proliferation, induces apoptosis or senescence, and maintains genome integrity. Mdm2 is also a target gene of p53 transcription factor. Thus, Mdm2 and p53 form a feedback regulatory loop. External and internal cues, through multiple signaling pathways, can act on Mdm2 to regulate p53 levels and cell proliferation, death, and senescence. This review will focus on how Mdm2 is regulated under genotoxic stress, and by the Akt1-mTOR-S6K1 pathway that is activated by insulin, growth factors, amino acids, or energy status.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21213101      PMCID: PMC4875075          DOI: 10.1007/s13238-010-0140-9

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  110 in total

1.  Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.

Authors:  S Fang; J P Jensen; R L Ludwig; K H Vousden; A M Weissman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

2.  The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.

Authors:  Min Sup Song; Su Jung Song; So Yeon Kim; Hyun Jung Oh; Dae-Sik Lim
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

Review 3.  ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.

Authors:  Erik Meulmeester; Yaron Pereg; Yosef Shiloh; Aart G Jochemsen
Journal:  Cell Cycle       Date:  2005-09-29       Impact factor: 4.534

4.  p53 mutant mice that display early ageing-associated phenotypes.

Authors:  Stuart D Tyner; Sundaresan Venkatachalam; Jene Choi; Stephen Jones; Nader Ghebranious; Herbert Igelmann; Xiongbin Lu; Gabrielle Soron; Benjamin Cooper; Cory Brayton; Sang Hee Park; Timothy Thompson; Gerard Karsenty; Allan Bradley; Lawrence A Donehower
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

5.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

6.  Roles for CSN5 in control of p53/MDM2 activities.

Authors:  Xiao-Chun Zhang; Jian Chen; Chun-Hui Su; Heng-Yin Yang; Mong-Hong Lee
Journal:  J Cell Biochem       Date:  2008-03-01       Impact factor: 4.429

7.  Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.

Authors:  Yaara Ofir-Rosenfeld; Kristy Boggs; Dan Michael; Michael B Kastan; Moshe Oren
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

8.  Controlling the Mdm2-Mdmx-p53 Circuit.

Authors:  David L Waning; Jason A Lehman; Christopher N Batuello; Lindsey D Mayo
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-18

9.  Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2.

Authors:  Susanne Pettersson; Michael Kelleher; Emmanuelle Pion; Maura Wallace; Kathryn L Ball
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

10.  Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination.

Authors:  Xin-Zi Chi; Jiyeon Kim; Yong-Hee Lee; Jung-Won Lee; Kyeong-Sook Lee; Heejun Wee; Wun-Jae Kim; Woo-Yoon Park; Byung-Chul Oh; Gary S Stein; Yoshiaki Ito; Andre J van Wijnen; Suk-Chul Bae
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

View more
  14 in total

Review 1.  Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping.

Authors:  Sunghoon Kim; Sungyong You; Daehee Hwang
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

2.  Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.

Authors:  Y M Yang; W H Lee; C G Lee; J An; E-S Kim; S H Kim; S-K Lee; C H Lee; D N Dhanasekaran; A Moon; S Hwang; S J Lee; J-W Park; K M Kim; S G Kim
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

3.  Chrysophanol, an anthraquinone from AST2017-01, possesses the anti-proliferative effect through increasing p53 protein levels in human mast cells.

Authors:  Na-Ra Han; Hee-Yun Kim; Soonsik Kang; Mi Hye Kim; Kyoung Wan Yoon; Phil-Dong Moon; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  Inflamm Res       Date:  2019-05-04       Impact factor: 4.575

4.  Murine double minute-2 expression is required for capillary maintenance and exercise-induced angiogenesis in skeletal muscle.

Authors:  Emilie Roudier; Paul Forn; Mary Ellen Perry; Olivier Birot
Journal:  FASEB J       Date:  2012-07-26       Impact factor: 5.191

5.  A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response.

Authors:  Jenny Fung Ling Chau; Deyong Jia; Zhongfeng Wang; Zhi Liu; Yuanyu Hu; Xin Zhang; Hao Jia; Keng Po Lai; Wai Fook Leong; Bi Jin Au; Yuji Mishina; Ye-Guang Chen; Christine Biondi; Elizabeth Robertson; Dong Xie; Huijuan Liu; Lin He; Xueying Wang; Qiang Yu; Baojie Li
Journal:  Nat Commun       Date:  2012-05-15       Impact factor: 14.919

6.  DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction.

Authors:  Zhiwei Wang; Hiroyuki Inuzuka; Jiateng Zhong; Hidefumi Fukushima; Lixin Wan; Pengda Liu; Wenyi Wei
Journal:  Oncotarget       Date:  2012-09

7.  Simulating molecular mechanisms of the MDM2-mediated regulatory interactions: a conformational selection model of the MDM2 lid dynamics.

Authors:  Gennady M Verkhivker
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

8.  The Role of p53 and MDM2 in Head and Neck Cancer.

Authors:  N Denaro; C Lo Nigro; G Natoli; E G Russi; V Adamo; M C Merlano
Journal:  ISRN Otolaryngol       Date:  2011-12-07

9.  Identification of 5-Iodotubercidin as a genotoxic drug with anti-cancer potential.

Authors:  Xin Zhang; Deyong Jia; Huijuan Liu; Na Zhu; Wei Zhang; Jun Feng; Jun Yin; Bin Hao; Daxiang Cui; Yuezhen Deng; Dong Xie; Lin He; Baojie Li
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

10.  Modulation of p53 expression using antisense oligonucleotides complementary to the 5'-terminal region of p53 mRNA in vitro and in the living cells.

Authors:  Agnieszka Gorska; Agata Swiatkowska; Mariola Dutkiewicz; Jerzy Ciesiolka
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.